Learn how IDT Biologika is responding to the COVID-19 outbreak


Dear Business Partner,

In face of the uncertainties of COVID-19 we want to assure you that we are taking our responsibility seriously. We are making every effort to protect our employees and to ensure the delivery of the vital vaccines and biologics of our clients for the health of people worldwide.

Regarding the availability and health of our employees we are committed to our pandemic preparedness plan. For sure the well-being of our employees and customers is our primary concern. IDT employees are following the recommendations from local authorities and respect safety measures as instructed.
All staff that are able to work from a remote location are doing so with meetings being held virtually.

In order to assure business continuity and maintenance of our development and manufacturing schedules we closely follow up our supply chain. Our priority is to focus our available resources on the management of operations.

Our contribution to keeping our communities safe is the short-term production of low level disinfectants for people who need them most: in hospitals, healthcare facilities, test centers, and for other people who are exposed to a direct risk.

Kind regards
Dr. Jürgen Betzing